Replies to post #182 on Sangamo Biosciences Inc (SGMO)

[surf1944]

4:21PM Sangamo BioSci beats by $0.05, beats on revs; guides FY13 revs in-line (SGMO) 9.42 +0.05 : Reports Q4 (Dec) loss of $0.07 per share, $0.05 better than the Capital IQ Consensus Estimate of ($0.12); revenues rose 88.4% year/year to $8.93 mln vs the $5.95 mln consensus. Co issues in-line guidance for FY13, sees FY13 revs of $20-24 mln vs. $23.08 mln Capital IQ Consensus Estimate.